Compare TSBK & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TSBK | PROF |
|---|---|---|
| Founded | 1915 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.0M | 243.2M |
| IPO Year | 1997 | 2017 |
| Metric | TSBK | PROF |
|---|---|---|
| Price | $40.69 | $6.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 18.2K | ★ 66.8K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | 21.93 | ★ 25.89 |
| EPS | ★ 1.94 | 0.19 |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | N/A | $92.40 |
| Revenue Next Year | N/A | $64.10 |
| P/E Ratio | ★ $20.86 | $36.37 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $29.30 | $3.92 |
| 52 Week High | $43.55 | $8.95 |
| Indicator | TSBK | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 52.54 | 48.30 |
| Support Level | $37.50 | $6.54 |
| Resistance Level | $42.40 | $7.07 |
| Average True Range (ATR) | 0.98 | 0.31 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 77.76 | 21.06 |
Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.